Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Buy
77
APGE Quote, Financials, Valuation and Earnings
Last price:
$76.85
Seasonality move
:
39.09%
Day range:
$74.36 - $77.09
52-week range:
$26.20 - $77.09
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.94x
Volume:
733.7K
Avg. volume:
738.2K
1-year change:
62.74%
Market cap:
$5.2B
Revenue:
--
EPS (TTM):
-$4.32
Earnings Data
Next earnings date for APGE
Mar 02
2026
Most recent earnings per share
-$1.11
Beat by $0.04
(Nov 10/2025)
Consensus Estimate
-$1.15
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
APGE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | -- | -- | -- | -$1.09 | -- |
| 11/10/2025 | Q3 | -- | -- | -$1.11 | -$1.15 | $0.04 |
| 08/11/2025 | Q2 | -- | -- | -$1.13 | -$1.05 | -$0.08 |
| 05/12/2025 | Q1 | -- | -- | -$0.95 | -$1.19 | $0.24 |
| 03/03/2025 | Q4 | -- | -- | -$1.13 | -$1.07 | -$0.06 |
| 11/12/2024 | Q3 | -- | -- | -$0.86 | -$0.74 | -$0.12 |
| 08/12/2024 | Q2 | -- | -- | -$0.60 | -$0.55 | -$0.05 |
| 05/13/2024 | Q1 | -- | -- | -$0.64 | -$0.65 | $0.01 |
| 03/05/2024 | Q4 | -- | -- | -$0.63 | -$0.55 | -$0.08 |
| 11/13/2023 | Q3 | -- | -- | -$0.41 | -$0.43 | $0.01 |
| 08/28/2023 | Q2 | -- | -- | -$0.37 | -$2.32 | $1.94 |
| 03/31/2023 | Q1 | -- | -- | -$0.25 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.51 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.39 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.04 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.09 | -- | -- |
Apogee Therapeutics, Inc. Earnings Questions
-
How Much did Apogee Therapeutics, Inc. Generate in Revenue Last Quarter?
Apogee Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Apogee Therapeutics, Inc. Beat Earnings Last Quarter?
Apogee Therapeutics, Inc. announced earnings per share of -$1.11 which represents a beat of analyst forecast a -$1.15 per share.
-
Is Apogee Therapeutics, Inc. Profitable?
Apogee Therapeutics, Inc. reported -$400K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Apogee Therapeutics, Inc. EPS Next Year?
Apogee Therapeutics, Inc.'s earnings are forecast to decrease from -$3.30 per share to -$3.09 per share next year representing a decrease of -27.74%.
-
When is Apogee Therapeutics, Inc.'s Earnings Date?
Apogee Therapeutics, Inc.'s next earnings date is March 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
